Ahmedabad-based Concord Biotech, supported by Rare Enterprises, has announced the price band of Rs 705-741 per share for its upcoming Initial Public Offering (IPO) worth Rs 1,550 crore. […]
Most long-only funds beat Nifty returns in June
Long-only alternative investment funds (AIF) have outperformed long-short funds in the month of June. The former gave average category returns of 5.2%, compared with 2.19% for the latter, […]